1.Treatment for acute ischemic stroke: new evidence from China.
Chinese Medical Journal 2013;126(18):3403-3404
3.Superior Vena Cava Syndrome Caused by Encircling Soft Tissue.
Dae Hyeok KIM ; Yong Sun JEON ; Gi Chang KIM ; In Sun AHN ; Jun KWAN ; Keum Soo PARK ; Woo Hyung LEE
The Korean Journal of Internal Medicine 2007;22(2):118-121
Superior vena cava syndrome can occur from benign conditions that might not alter life expectancy. Here we present a case of a superior vena cava (SVC) obstruction caused by soft tissue encircling the SVC, which was strongly suspected of being an unusual focal type of fibrosing mediastinitis. A 39-year-old man with no prior medical history presented with a four-week history of facial plethora, headache and dilated veins of the neck with a dark purple color change on the anterior chest wall. Radiology examinations, including venography, and computed tomography with a 3-dimensional volume-rendering image of the chest, had revealed severe narrowing of the SVC due to tiny encircling soft tissue and collateral vessels. A total occlusion of the SVC occurred as a result of a thrombus that developed within 1 day after the diagnostic SVC angiogram. The patient underwent stent deployment three days after the administration of thrombolytic therapy.
Adult
;
Fibrinolytic Agents/therapeutic use
;
Humans
;
Male
;
*Stents
;
Superior Vena Cava Syndrome/*diagnosis/etiology/surgery
8.Fibrinolysis of loculated pleural effusion in malignant mesothelioma.
Singapore medical journal 2005;46(3):148-reply 148
10.The effect of batroxobin on atherosclerosis.
Juan HUANG ; Dong ZHOU ; Linyu TIAN ; Hongtao WU ; Jie ZHANG ; Shangfu ZHANG ; Huaiqing CHEN
Journal of Biomedical Engineering 2003;20(2):197-201
To study the effect of batroxobin(DF-521) on atherosclerosis, we divided 50 Japanese big ear rabbits into control group and high-lipid group. After the atherosclerosis model was successfully established, the high-lipid rabbits were divided into 3 groups(placebo group, treatment group 1 and treatment group 2). Batroxobin was injected in the treatment groups, and saline was injected in placebo group and control group. Getting the aorta before, inter and after treatment, dyeing the lipid, endothelium, smooth muscle, collagen fibers of the vascular plaque(the elastic fibers are of autofluorescence), we observed them with the light microscope and laser scanning confocal microscope. From the results, we found that the atherosclerotic plaque in the treatment groups, tended to be static four weeks later, but there was no obvious difference between treatment group 1 and treatment group 2. These implied that batroxobin possessed the action of stabilizing the atherosclerotic plaque, but the dosage-effect was not clear and the principle needed more study.
Animals
;
Arteriosclerosis
;
drug therapy
;
pathology
;
Batroxobin
;
therapeutic use
;
Disease Models, Animal
;
Female
;
Fibrinolytic Agents
;
therapeutic use
;
Male
;
Rabbits